12:00 AM
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BiodivYsio stent: Marketed

In a 426-patient study comparing BII’s BiodivYsio stents to historical controls, patients treated with the stents had an 11 percent rate of major adverse cardiac events compared to 16 percent historically, a 6.2 percent rate of target vessel...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >